The Korean Journal of Medicine

The Korean Association of Internal Medicine (대한내과학회)
권호 표지

Progress in Pancreas Transplantation in Korea

국내에서의 췌장이식의 경과

  • Cheon, Young-Koog (Institute for Digestive Research and Digestive Disease Center, Soonchunhyang University College of Medicine)
  • 천영국 (순천향대학교 의과대학 내과학교실.소화기연구소)
  • Published : 2011.02.01
⟨ Previous Next ⟩

Abstract

Pancreas transplantation is the most effective cure for type I diabetes because it is able to restore normal glucose homeostasis. Over the last 2 decades, improvements in immunosuppressive therapy have been paralleled by a marked decrease in surgical complications, by superior antimicrobial prophylaxis and therapy, and by better techniques for diagnosing and treating pancreas graft rejection. The result has been a steady increase in the number of pancreas transplants. However, differently from heart, lung and liver transplantation, pancreas transplantation cannot be considered a life-saving procedure and the advantages in the long term should be carefully considered and balanced with the morbidity and mortality associated to the surgical procedure and the side-effect of immunosuppression.

Keywords

References

  1. Gruessner AC, Sutherland DER, Grueener RWG. Pancreas transplantation in the United States: a review. Curr Opin Organ Transplant 2010;15:93-101. https://doi.org/10.1097/MOT.0b013e32833552d2
  2. 한덕종, 김송철, 박재범 등. 국내 단일기관에서 시행한 췌장이식의 임상적인 결과. 대한내과학회지 2011;80:167-178.
  3. Remuzzi G, Ruggenenti P, Mauer SM. Pancreas and kidney/pancreas transplants: experimental medicine or real improvement? Lancet 1994;343:27-31. https://doi.org/10.1016/S0140-6736(94)90880-X
  4. Fioretto P, Steffes MW, Sutherland DE, Goetz FC, Mauer M. Reversal of lesions of diabetic nephropathy after pancreas transplantation. N Engl J Med 1998;339:69-75. https://doi.org/10.1056/NEJM199807093390202
  5. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977-986. https://doi.org/10.1056/NEJM199309303291401
  6. Johansson BL, Kernell A, Sjoberg S, Wahren J. Influence of combined C-peptide and insulin administration on renal function and metabolic control in diabetes type I. J Clin Endocrinol Metab 1993;77:976-981. https://doi.org/10.1210/jc.77.4.976
  7. Gruessner AC, Sutherland DE. Pancreas transplant outcomes for United States (US) cases as reported to the United Network for Organ Sharing (UNOS) and the International Pancreas Transplant Registry (IPTR). In: Cecka JM, Terasaki, editors. Clinical Transplants 2008. Los Angeles: UCLA Tissue Typing Laboratory 2009; 45-56.
  8. Dew MA, Switzer GE, Goycoolea JM, et al. Does transplantation produce quality of life benefits? A quantitative analysis of the literature. Transplantation 1997;64:1261-1273. https://doi.org/10.1097/00007890-199711150-00006
  9. Luzi L, Hering BJ, Socci, et al. Metabolic effects of successful intraportal islet transplantation in insulin-dependent diabetes mellitus. J Clin Invest 1996;97:2611-2618. https://doi.org/10.1172/JCI118710